ShanXi C&Y Pharmaceutical Group Co., Ltd. (300254.SZ)
CNY 9.27
(1.64%)
CNY 9.27
(1.64%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 37.81 Million | 74.87 Million | 96.92 Million | -20.87 Million | 69.63 Million | 38.44 Million |
| Net Income | 48.72 Million | -97.99 Million | -74.54 Million | -280.57 Million | -1.77 Million | 9.76 Million |
| Depreciation & Amortization | 58.52 Million | 64.78 Million | 66.92 Million | 64.81 Million | 52.26 Million | 56.1 Million |
| Deferred income taxes | -2.29 Million | 759.4 Thousand | -558.34 Thousand | -21.26 Million | -2.7 Million | -5.04 Million |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -68.27 Million | 7.14 Million | 33.67 Million | 53.09 Million | -18.57 Million | -96.15 Million |
| Other non-cash items | -1.16 Million | 100.93 Million | 70.86 Million | 141.78 Million | 37.71 Million | 68.72 Million |
| Investing Cash Flow | 72.1 Million | -23.19 Million | -25.2 Million | -5.41 Million | -349.11 Million | -23.16 Million |
| Investments in PPE | -33.91 Million | -26.78 Million | -36.92 Million | -31.46 Million | -18.54 Million | -29.58 Million |
| Acquisitions | 100.83 Million | 2.11 Million | 6.41 Million | 3.16 Million | 21.86 Million | 1.27 Million |
| Investment purchases | -100.83 Million | -2.11 Million | -2.2 Million | -90 Million | -721.1 Million | - |
| Sales/Maturities of investments | 5.18 Million | 1.46 Million | 7.77 Million | 106.34 Million | 387.2 Million | - |
| Other Investing Activities | 100.83 Million | 2.11 Million | -270 Thousand | 6.54 Million | -18.54 Million | 5.15 Million |
| Financing Cash Flow | -241.77 Million | 112.56 Million | -152.29 Million | 63.33 Million | 275.02 Million | -16.21 Million |
| Debt repayment | -125.21 Million | -223.42 Million | -189.52 Million | -242.52 Million | -160.2 Million | -306.2 Million |
| Dividends payments | -13.31 Million | -11.9 Million | -14.67 Million | -20.82 Million | -4.16 Million | -35.92 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -103.24 Million | 347.88 Million | 51.89 Million | 326.67 Million | 454.88 Million | 325.91 Million |
| Accounts receivables | -5.34 Million | -120.83 Million | 119.47 Million | 44.68 Million | -16.39 Million | -57.62 Million |
| Accounts payables | -40.01 Million | 123.4 Million | -91.55 Million | 23.3 Million | 1.88 Million | -30.41 Million |
| Inventory | -20.61 Million | 3.8 Million | 6.31 Million | 6.36 Million | -1.35 Million | -3.07 Million |
| Other working capital | -2.29 Million | 759.4 Thousand | -558.34 Thousand | -21.26 Million | -2.7 Million | -93.08 Million |
| Cash at beginning of period | 263.84 Million | 99.6 Million | 180.18 Million | 143.13 Million | 147.59 Million | 148.52 Million |
| Cash at end of period | 131.99 Million | 263.84 Million | 99.6 Million | 180.18 Million | 143.13 Million | 147.59 Million |
| Capital Expenditure | -33.91 Million | -26.78 Million | -36.92 Million | -31.46 Million | -18.54 Million | -29.58 Million |
| Effect of forex changes on cash | 0.20 | -0.16 | - | 5865.35 | - | 0.90 |
| Net cash flow / Change in cash | -131.85 Million | 164.24 Million | -80.58 Million | 37.04 Million | -4.45 Million | -931.65 Thousand |
| Free Cash Flow | 3.89 Million | 48.09 Million | 59.99 Million | -52.33 Million | 51.09 Million | 8.85 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.65 Million | 15.21 Million | 18.28 Million | 38.88 Million | 48.72 Million | 10.43 Million |
| Depreciation & Amortization | - | 14.46 Million | 14.46 Million | 13.59 Million | 58.52 Million | 13.59 Million |
| Deferred income taxes | - | - | - | - | -2.29 Million | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -25.96 Million | -68.27 Million | 2.79 Million |
| Other non-cash items | -8.05 Million | 24.23 Million | 17.2 Million | 458.66 Thousand | -1.16 Million | -16.6 Million |
| Investing Cash Flow | -10.19 Million | -2.55 Million | -46.62 Million | -15.35 Million | 72.1 Million | 3.45 Million |
| Investments in PPE | -11.83 Million | -2.58 Million | -46.64 Million | -16.17 Million | -33.91 Million | -1.74 Million |
| Acquisitions | 1.63 Million | 35.2 Thousand | 19.45 Thousand | 100.81 Million | 100.83 Million | 13.46 Thousand |
| Investment purchases | - | - | - | - | -100.83 Million | 94.8 Million |
| Sales/Maturities of investments | - | - | - | - | 5.18 Million | -94.81 Million |
| Other Investing Activities | 1.63 Million | 35.2 Thousand | 19.45 Thousand | -99.99 Million | 100.83 Million | 5.19 Million |
| Financing Cash Flow | 39.55 Million | -9.83 Million | 11.05 Million | -20.23 Million | -241.77 Million | -230.58 Million |
| Debt repayment | -19.16 Million | -3.03 Million | -20.42 Million | -41.25 Million | -125.21 Million | -68.5 Million |
| Dividends payments | -3.02 Million | -3.04 Million | -2.92 Million | -2.95 Million | -13.31 Million | -3.51 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 23.42 Million | -3.75 Million | -9.36 Million | 23.97 Million | -103.24 Million | -158.57 Million |
| Accounts receivables | - | - | - | -5.34 Million | -5.34 Million | -16.69 Million |
| Accounts payables | - | - | - | - | -40.01 Million | - |
| Inventory | - | - | - | -20.61 Million | -20.61 Million | 19.49 Million |
| Other working capital | - | - | - | - | -2.29 Million | - |
| Cash at beginning of period | 144.5 Million | 131.9 Million | 131.99 Million | 140.6 Million | 263.84 Million | 357.52 Million |
| Cash at end of period | 176.46 Million | 144.5 Million | 131.91 Million | 131.99 Million | 131.99 Million | 140.6 Million |
| Capital Expenditure | -11.83 Million | -2.58 Million | -46.64 Million | -16.17 Million | -33.91 Million | -1.74 Million |
| Effect of forex changes on cash | - | - | 11 Thousand | 0.08 | 0.20 | 0.61 |
| Net cash flow / Change in cash | 31.96 Million | 12.59 Million | -74.49 Thousand | -8.61 Million | -131.85 Million | -216.91 Million |
| Free Cash Flow | -9.23 Million | 22.39 Million | -11.16 Million | 10.8 Million | 3.89 Million | 8.47 Million |
1460
LEO
1062
LLY
4391
IE